Dr. Peter Costantino, MD, specializes in cranial base surgery and adult craniofacial reconstruction, having performed over 500 cranioplasties—most using implants of his own design. He has developed minimally invasive techniques for the endoscopic removal of recurrent nasopharyngeal cancer and has participated in one of the largest chordoma resection series in the world.

Dr. Costantino has published more than 170 peer-reviewed articles, chapters, and abstracts, and delivered over 300 lectures. Notably, he reported the first use of distraction osteogenesis to regrow a missing segment of the mandible in a human. He has served as Principal Investigator or Co-Principal Investigator on multiple IRB studies, including one that led to FDA clearance of a new category of implantable biomaterials (hydroxyapatite cement).

He is the only surgeon to have twice received both the Ben Shuster Basic Research Award and the Ira Tresley Research Award from the American Academy of Facial Plastic & Reconstructive Surgery. He has also received the Ralph Millard Award for outstanding basic research from the Plastic Surgery Educational Foundation.

Dr. Costantino is dual board-certified in Otolaryngology–Head & Neck Surgery and Facial Plastic & Reconstructive Surgery, and is Joint Council Certified in Head & Neck Surgical Oncology. In 2007, he founded and became Executive Director of the New York Head & Neck Institute. He earned his medical degree with highest honors from Northwestern University School of Medicine and completed his undergraduate studies at the University of Notre Dame.

Dr. Costantino has been recognized by Castle Connolly as one of the nation’s top doctors in Otolaryngology, Oncology, and the field of Oncology nearly every year for the past two decades.